MIDAS

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome (MIDAS)

Near Add Your Location

Sorting 5 by

Center of Excellence

Smilow Cancer Hospital at Yale New Haven
New Haven, CT
  • Accepting patients

Center of Excellence

City of Hope Comprehensive Cancer Center
Beckman Research Institute
Duarte, CA
  • Accepting patients
City of Hope
Goodyear, AZ
  • Accepting patients
Gabrail Cancer Center Research
Canton, OH
  • Accepting patients
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.